NEW YORK (GenomeWeb) – Sygnis today announced a non-exclusive distribution agreement with Sopachem for the commercialization of TruePrime products.
Under the terms of the agreement, Sopachem will promote, market, sell, and support TruePrime products for primer-free whole genome amplification in Belgium.
TruePrime products use Sygnis' multiple displacement amplification technology based on DNA primase TthPrimPol and Phi29 polymerase.
Belgium-based Sopachem is a specialized distributor with a focus on life sciences, diagnostics, and biobanking. The firm also has operations in the Netherlands and Luxembourg.